User profiles for Meilan Han

MeiLan K. Han

University of Michigan
Verified email at umich.edu
Cited by 31420

Chronic obstructive pulmonary disease phenotypes: the future of COPD

MLK Han, A Agusti, PM Calverley, BR Celli… - American journal of …, 2010 - atsjournals.org
… Correspondence and requests for reprints should be addressed to MeiLan K. Han, MD,
MS, University of Michigan - Pulmonary and Critical Care, 1500 E. Medical Center Drive, 3916 …

[HTML][HTML] Analysis of the lung microbiome in the “healthy” smoker and in COPD

JR Erb-Downward, DL Thompson, MK Han… - PloS one, 2011 - journals.plos.org
Although culture-independent techniques have shown that the lungs are not sterile, little is
known about the lung microbiome in chronic obstructive pulmonary disease (COPD). We …

Gender and chronic obstructive pulmonary disease: why it matters

MLK Han, D Postma, DM Mannino… - American journal of …, 2007 - atsjournals.org
The prevalence of chronic obstructive pulmonary disease (COPD) in women is increasing,
as is hospitalization for COPD. The number of women dying of COPD in the United States …

Undiagnosed obstructive lung disease in the United States. Associated factors and long-term mortality

…, FA Jaimes, JL Curtis, MLK Han… - Annals of the …, 2015 - atsjournals.org
Rationale: Understanding factors associated with undiagnosed obstructive lung disease
and its impact on mortality could inform the ongoing discussions about benefits and risks of …

[HTML][HTML] Once-daily single-inhaler triple versus dual therapy in patients with COPD

…, MT Dransfield, DMG Halpin, MLK Han… - … England Journal of …, 2018 - Mass Medical Soc
Background The benefits of triple therapy for chronic obstructive pulmonary disease (COPD)
with an inhaled glucocorticoid, a long-acting muscarinic antagonist (LAMA), and a long-…

Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes

MLK Han, EA Kazerooni, DA Lynch, LX Liu, S Murray… - Radiology, 2011 - pubs.rsna.org
Purpose To test the hypothesis—given the increasing emphasis on quantitative computed
tomographic (CT) phenotypes of chronic obstructive pulmonary disease (COPD)—that a …

[HTML][HTML] Azithromycin for prevention of exacerbations of COPD

…, JL Curtis, MT Dransfield, MLK Han… - … England Journal of …, 2011 - Mass Medical Soc
Background Acute exacerbations adversely affect patients with chronic obstructive pulmonary
disease (COPD). Macrolide antibiotics benefit patients with a variety of inflammatory …

Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019

…, GJ Criner, P Frith, DMG Halpin, M Han… - European …, 2019 - Eur Respiratory Soc
Precision medicine is a patient-specific approach that integrates all relevant clinical, genetic
and biological information in order to optimise the therapeutic benefit relative to the …

[HTML][HTML] Goals of COPD treatment: focus on symptoms and exacerbations

…, M Roman-Rodriguez, D Singh, MLK Han… - Respiratory …, 2020 - Elsevier
Chronic obstructive pulmonary disease (COPD) is currently a leading cause of death
worldwide, and its burden is expected to rise in the coming years. Common COPD symptoms …

Computed tomography–based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression

CJ Galbán, MK Han, JL Boes, KA Chughtai… - Nature medicine, 2012 - nature.com
Chronic obstructive pulmonary disease (COPD) is increasingly being recognized as a highly
heterogeneous disorder, composed of varying pathobiology. Accurate detection of COPD …